These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34918690)

  • 1. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort.
    Zhang R; Li Y; Zhou X; Zhang F; Li M; Zhang S; Zhang X; Wen X; Ji L
    Medicine (Baltimore); 2021 Dec; 100(50):e28238. PubMed ID: 34918690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis.
    Anuwatmatee S; Allison MA; Shlipak MG; McClelland RL; Kramer H; Tang S; Hou L; Rye KA; Ong KL
    Nephrol Dial Transplant; 2019 Jun; 34(6):1009-1016. PubMed ID: 29771383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese.
    Lin Z; Zhou Z; Liu Y; Gong Q; Yan X; Xiao J; Wang X; Lin S; Feng W; Li X
    PLoS One; 2011 Apr; 6(4):e18398. PubMed ID: 21525989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease.
    Gómez-Sámano MÁ; Vargas-Abonce VP; Martínez-Sánchez FD; Palacios-Báez L; Vera-Zertuche JM; Navarro-Flores MF; Morales-García MG; Fonseca-Correa JI; Zuarth-Vázquez JM; Vega-Vega O; Correa-Rotter R; Rincón-Pedrero R; Morales-Buenrostro LE; Alberú-Gómez J; Ramírez-González JB; Pacheco-Domínguez RL; López-Cervantes M; Mendoza-de-la-Garza MLÁ; Baeza-Arias YV; Espinosa-Cuevas Á; López-Carrasco G; López-Estrada A; Guillén-Pineda LE; Gómez-Pérez FJ; Cuevas-Ramos D
    Ther Adv Endocrinol Metab; 2021; 12():20420188211001160. PubMed ID: 33854753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of the adipokine FGF21 depend on renal function.
    Stein S; Bachmann A; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Diabetes Care; 2009 Jan; 32(1):126-8. PubMed ID: 18840768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
    Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans.
    Song YM; Sung J; Lee K
    Clin Exp Nephrol; 2017 Jun; 21(3):474-480. PubMed ID: 27339447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events.
    Wu L; Qian L; Zhang L; Zhang J; Zhou J; Li Y; Hou X; Fang Q; Li H; Jia W
    J Am Heart Assoc; 2020 Jun; 9(11):e015226. PubMed ID: 32431189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.
    Kuwabara M; Bjornstad P; Hisatome I; Niwa K; Roncal-Jimenez CA; Andres-Hernando A; Jensen T; Milagres T; Sato Y; Garcia G; Ohno M; Lanaspa MA; Johnson RJ
    Am J Nephrol; 2017; 45(4):330-337. PubMed ID: 28285309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
    Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index is an independent predictive factor for kidney function evaluated by glomerular filtration rate in a community-dwelling population.
    Duan Y; Wang X; Zhang J; Ye P; Cao R; Yang X; Bai Y; Wu H
    Eat Weight Disord; 2019 Aug; 24(4):731-738. PubMed ID: 28871501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.
    Fan F; Jia J; Li J; Huo Y; Zhang Y
    BMC Nephrol; 2017 Jun; 18(1):190. PubMed ID: 28592280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 (FGF21) in children and adolescents with chronic kidney disease.
    Gamrot Z; Adamczyk P; Świętochowska E; Roszkowska-Bjanid D; Gamrot J; Szczepańska M
    Physiol Res; 2020 Jul; 69(3):451-460. PubMed ID: 32469231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.
    Ong KL; Januszewski AS; O'Connell R; Buizen L; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Rye KA; Keech AC;
    Diabetologia; 2015 Sep; 58(9):2035-44. PubMed ID: 26055067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR > 60 mL/min/1.73 m
    Zhou F; Yu G; Wang G; Liu Y; Zhang L; Wang W; Chen N
    Clin Exp Nephrol; 2019 Jul; 23(7):871-879. PubMed ID: 30734168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.
    Choi JR; Kim JY; Park IH; Huh JH; Kim KW; Cha SK; Park KS; Sohn JH; Park JT; Koh SB
    Yonsei Med J; 2018 Mar; 59(2):287-293. PubMed ID: 29436198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variants Flanking the
    Yu W; Zhu H; Chen X; Gu X; Zhang X; Shen F; Jia W; Hu C
    J Diabetes Res; 2019; 2019():9387358. PubMed ID: 31205953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.